Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TNF | P01375 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26184965 | 0.96 | MAPT (0.38) | GPR55ALDH1A1HSD17B10HPGDMAPK1 | |
| SCHEMBL28264477 | 0.84 | ESR1 (0.42) | ALDH1A1HSD17B10HPGDMAPTNFKB1 | |
| SCHEMBL28320847 | 0.84 | ADORA3 (0.43) | ALDH1A1HSD17B10HPGDMAPK1KDM4E | |
| SCHEMBL28217059 | 0.84 | SMN1; SMN2 (0.46) | ALDH1A1HSD17B10HPGDMAPK1KDM4E | |
| SCHEMBL28869311 | 0.84 | XDH (0.33) | ALDH1A1HSD17B10HPGDMAPK1KDM4E | |
| SCHEMBL28216640 | 0.84 | HTR1A (0.41) | TP53SMN1; SMN2ADORA2AADORA1HTR1A | |
| SCHEMBL9825550 | 0.83 | SLC22A12 (0.40) | GPR55ALDH1A1HSD17B10HPGDNFKB1 | |
| SCHEMBL21879687 | 0.80 | IMPDH2 (0.38) | DRD2 | |
| SCHEMBL28264478 | 0.78 | HPGD (0.43) | ALDH1A1HSD17B10HPGDKDM4EMAPT | |
| SCHEMBL27988315 | 0.77 | PTGS2 (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2797862-B1 | OLEFIN OLIGOMERIZATION METHODS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2021-04-07 | — | — | EP | disclosed |
| US-10790456-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2020-09-29 | — | — | US | disclosed |
| EP-3335253-B1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2019-08-21 | — | — | EP | disclosed |
| EP-3184171-B1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2019-03-20 | — | — | EP | disclosed |
| EP-2858750-B1 | PHOSPHINYL GUANIDINE COMPOUNDS, CHROMIUM SALT COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2019-03-13 | — | — | EP | disclosed |
| CN-109311844-A | Triaizine compounds, its manufacturing method and the organic electroluminescent device as constituent | 东曹株式会社 | 2019-02-05 | — | — | CN | disclosed |
| US-10144752-B2 | Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2018-12-04 | — | — | US | disclosed |
| CN-106083927-B | Phosphino- amidine compound, metal complex, antigravity system and their oligomeric or olefin polymerization purposes | 切弗朗菲利浦化学公司 | 2018-10-26 | — | — | CN | disclosed |
| EP-2790828-B1 | PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2018-09-19 | — | — | EP | disclosed |
| EP-2791091-B1 | PREPARATION OF CHROMIUM(III) CARBOXYLATES | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2018-09-19 | — | — | EP | disclosed |
| WO-2011137027-A1 | OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2011-11-03 | — | — | WO | disclosed |
| WO-2011130170-A1 | OLIGOMERIZATION OF BIS(BETA-HYDROXY) POLYSULFIDES THROUGH ETHERIFICATION | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2011-10-20 | — | — | WO | disclosed |
| US-20110251358-A1 | OLIGOMERIZATION OF BIS(BETA-HYDROXY) POLYSULFIDES THROUGH ETHERIFICATION | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2011-10-13 | — | — | US | disclosed |
| CN-102164672-A | Oligomerization catalyst system and process for oligomerizing olefins | CHEVRON PHILLIPS CHEMICAL CO | 2011-08-24 | — | — | CN | disclosed |
| EP-2349562-A1 | OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS | Chevron Phillips Chemical Company LP (US) | 2011-08-03 | — | — | EP | disclosed |
| WO-2011082192-A1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2011-07-07 | — | — | WO | disclosed |
| US-20100274065-A1 | OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-10-28 | — | — | US | disclosed |
| US-20100113852-A1 | OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-05-06 | — | — | US | disclosed |
| WO-2010051415-A1 | OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-05-06 | — | — | WO | disclosed |
| WO-2004069840-A2 | PRODUCTION OF TETRAHYDROQUINOLINE BENZOFURANS | Grünenthal GmbH (DE) | 2004-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10790456-B2 | Materials for electronic devices | SOD1, GPX1, L1CAM | GPR55 4844/4885ALDH1A1 288/4885HSD17B10 3248/4885 |
| US-10144752-B2 | Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins | NIT2, NCLN, NPM1 | GPR55 4758/4885ALDH1A1 4849/4885HSD17B10 4182/4885 |
| US-20100274065-A1 | OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS | DHPS, PPOX, HPD | GPR55 2965/4885ALDH1A1 3910/4885HSD17B10 1762/4885 |
| US-20100113852-A1 | OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS | DHPS, COG5, PPOX | GPR55 1640/4885ALDH1A1 3601/4885HSD17B10 2449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.